News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Newly Formed Azidex Pharmaceuticals, Inc. Gets $500K Seed Round From PA Early Stage Partners


10/19/2005 5:09:15 PM

9/8/2005. Azidex Pharmaceuticals Inc., a developer of HIV drugs to treat viral strains resistant to existing medications such as azidothymidine, or AZT, said it received $500,000 of seed financing from PA Early Stage Partners.



comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES